Podcasts & RSS Feeds
Most Active Stories
- Investigators Ask For Public's Help In Ongoing Abigail Hernandez Investigation
- Adults Who Wear Kids' Clothing: Saving Money Through Size
- Star Island Seeks To Go Solar, Serve As Energy Example
- Bare Shelves, High Spirits As Market Basket Employees Continue Rally
- On Demand: What's New To Netflix, Redbox, And Amazon Prime For July 2014
Wed April 23, 2014
New Painkiller Zohydro Stokes Concerns In N.H.
The FDA has approved this drug, but across New England there’s worry that the drug will only add fuel to the fire of the region’s opiate addiction problem. Lawmakers, governors, health care leaders, are all weighing in with different ideas about how to avoid abuse and yet still help those patients in pain.
- Dr. Gil Fanciullo – professor of anesthesiology at Dartmouth Medical School and director of pain management at Dartmouth-Hitchcock Medical Center, which has said its physicians will not prescribe Zohydro
- Peggy Gilmour – Democratic Senator from Hollis. She has a background in nursing and hospice care, and has served on the Health, Education, and Human Services Committee.
- Dr. Joshua Greenspan – founder of American Pain Institute in Portsmouth. He’s Board Certified in the Specialty of Pain Management.
- James Vara - Assistant Attorney General and head the Drug Prosecution Unit
All Things Considered